Document is current

Article History

Received: 20 October 2018

Accepted: 5 December 2018

First Online: 29 December 2018

Ethics approval and consent to participate

: This study was approved by the ethics committee of Dana-Farber Cancer Institute and Brigham and Women’s Hospital. Written informed consent to publish their clinical data was obtained from each patient before the initiation of the study.

: All patients prospectively provided signed informed consent for an Institutional Review Board-approved protocol for research use of medical records, of pathologic specimens obtained as part of routine clinical care, and publication.

: AJW; Consulting: Five Prime, Eli Lilly, Loxo Research Funding to the institution: Five Prime, Daiichi-Sankyo, Plexxikon, Eli Lilly, Karyopharm, AADi.*The other authors do not have any competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.